Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;67(2):423-436.
doi: 10.1007/s10620-021-06899-2. Epub 2021 Feb 24.

Pancreatic Disorders in Patients with Inflammatory Bowel Disease

Marilia L Montenegro  1 , Juan E Corral  1 , Frank J Lukens  1 , Baoan Ji  2 , Paul T Kröner  1 , Francis A Farraye  1 , Yan Bi  3
Affiliations
Review

Pancreatic Disorders in Patients with Inflammatory Bowel Disease

Marilia L Montenegro et al. Dig Dis Sci. 2022 Feb.

Abstract

Inflammatory bowel disease (IBD) can involve multiple organ systems, and pancreatic manifestations of IBD are not uncommon. The incidence of several pancreatic diseases is more frequent in patients with Crohn's disease and ulcerative colitis than in the general population. Pancreatic manifestations in IBD include a heterogeneous group of disorders and abnormalities ranging from mild, self-limited disorders to severe diseases. Asymptomatic elevation of amylase and/or lipase is common. The risk of acute pancreatitis in patients with IBD is increased due to the higher incidence of cholelithiasis and drug-induced pancreatitis in this population. Patients with IBD commonly have altered pancreatic histology and chronic pancreatic exocrine dysfunction. Diagnosing acute pancreatitis in patients with IBD is challenging. In this review, we discuss the manifestations and possible causes of pancreatic abnormalities in patients with IBD.

Keywords: Crohn’s disease; Extraintestinal manifestations; Inflammatory bowel disease; Pancreatitis; Ulcerative colitis.

PubMed Disclaimer

References

    1. Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB. Prevalence of inflammatory bowel disease among adults aged >/=18 years - United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1166–1169. https://doi.org/10.15585/mmwr.mm6542a3 . - DOI - PubMed
    1. Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease—epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019;13:307–317. https://doi.org/10.1080/17474124.2019.1574569 . - DOI - PubMed
    1. Bokemeyer B. Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn’s disease and ulcerative colitis. Z Gastroenterol. 2002;40:5–10. https://doi.org/10.1055/s-2002-19636 . - DOI - PubMed
    1. Katz S, Bank S, Greenberg RE, Lendvai S, Lesser M, Napolitano B. Hyperamylasemia in inflammatory bowel disease. J Clin Gastroenterol. 1988;10:627–630. https://doi.org/10.1097/00004836-198812000-00010 . - DOI - PubMed
    1. Tromm A, Holtmann B, Huppe D, Kuntz HD, Schwegler U, May B. Hyperamylasemia, hyperlipasemia and acute pancreatitis in chronic inflammatory bowel diseases. Leber Magen Darm. 1991;21:15–16 (9-22). - PubMed

MeSH terms

LinkOut - more resources